DGX · Quest Diagnostics

S&P 500 #364 · NYSE

Risiko 3/10 · Healthcare services compounder · $235.94 ▲ 1.77%

Kennzahlen

• Price $235.94
• Market cap $26.0B
• P/E (ttm) 25.07
• Div yield 1.48%
• 52-wk range $166.75 – $240.03
• Index rank #364 / —

Wichtigste Risiken

• Medicare/Medicaid reimbursement rate pressure (Revenue) — MED
• Competition from hospital in-house labs (Market share) — LOW
• Integration risk from lab acquisitions (Margins) — LOW
• AI diagnostics potentially disintermediating testing (Long-term demand) — LOW

Fazit

Quest Diagnostics is the largest U.S. clinical lab network, processing ~500K patient encounters daily with a defensive recurring-revenue model.

Interaktive Analyse öffnen → Teilen

Recherche, keine Anlageberatung.